Accordingly, topical application of the TLR7 agonist imiquimod, a common murine model for IL23- and IL17-dependent psoriasis, induced a higher degree of inflammation in GILZ deficient mice via upregulation of Th17-inducing cytokines by dendritic cells and Th17 proliferation. The gene discussed is TSC22D3; the disease is psoriasis.